|
Puromycin Aminonucleoside
|
D011692 |
[PUROMYCIN derivative that lacks the methoxyphenylalanyl group on the amine of the sugar ring. It is an antibiotic with antineoplastic properties and can cause nephrosis.
] |
|
Purpura
|
D011693 |
[Pinhead size (3 mm) skin discolorization due to hemorrhage.
, Purplish or brownish red discoloration, easily visible through the epidermis, caused by hemorrhage into the tissues. When the size of the discolorization is >2-3 cm it is generally called Ecchymoses (ECCHYMOSIS).
] |
|
Heart Failure, Systolic
|
C14.280.434.676 |
|
|
Purpura, Hyperglobulinemic
|
D011694 |
[Purplish or brownish red discoloration of the skin associated with increase in circulating polyclonal globulins, usually GAMMA-GLOBULINS. This syndrome often occurs on the legs of women aged 20 to 40 years.
] |
|
Patient Admission
|
N02.421.585.400.600 |
|
|
Purpura, Schoenlein-Henoch
|
D011695 |
[A systemic non-thrombocytopenic purpura caused by HYPERSENSITIVITY VASCULITIS and deposition of IGA-containing IMMUNE COMPLEXES within the blood vessels throughout the body, including those in the kidney (KIDNEY GLOMERULUS). Clinical symptoms include URTICARIA; ERYTHEMA; ARTHRITIS; GASTROINTESTINAL HEMORRHAGE; and renal involvement. Most cases are seen in children after acute upper respiratory infections.
] |
|
Purpura, Thrombocytopenic
|
D011696 |
[Any form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms.
] |
|
3-alpha-Hydroxysteroid Dehydrogenase (B-Specific)
|
D045002 |
[A 3-hydroxysteroid dehydrogenase which catalyzes the reversible reduction of the active androgen, DIHYDROTESTOSTERONE to 5 ALPHA-ANDROSTANE-3 ALPHA,17 BETA-DIOL. It also has activity towards other 3-alpha-hydroxysteroids and on 9-, 11- and 15- hydroxyprostaglandins. The enzyme is B-specific in reference to the orientation of reduced NAD or NADPH.
] |
|
Alum Compounds
|
D01.875.800.800.850.025 |
|
|
Tibet
|
Z01.252.474.164.900 |
|
|
Pharmacogenetics
|
H01.158.703.052 |
|
|
Bacteriophage T4
|
B04.280.090.500.350 |
|
|
Janus Kinase 1
|
D08.811.913.696.620.682.725.124.100 |
|
|
Neurofibromatosis 2
|
C10.292.910.600.500 |
|
|
Neuroma, Acoustic
|
C10.292.910.600 |
|
|
Mutation Rate
|
D059645 |
[The number of mutations that occur in a specific sequence, GENE, or GENOME over a specified period of time such as years, CELL DIVISIONS, or generations.
] |
|
Myxomatosis, Infectious
|
C22.627 |
|
|
Genome Size
|
D059646 |
[The amount of DNA (or RNA) in one copy of a genome.
] |
|
Gene-Environment Interaction
|
D059647 |
[The combined effects of genotypes and environmental factors together on phenotypic characteristics.
] |
|
Kisspeptins
|
D059648 |
[Intercellular signaling peptides that were originally characterized by their ability to suppress NEOPLASM METASTASIS. Kisspeptins have since been found to play an important role in the neuroendocrine regulation of REPRODUCTION.
] |
